P1027: Optimizing IBD Medication and Therapy: An Interdisciplinary University Outpatient ApproachECCO'24Year: 2024
Authors: Binder, B.(1)*;Elger, T.(1);Huss, M.(1);Loibl, J.(1);Tews, H.C.(1);Kandulski, A.(1);Kratzer, A.(2);Müller, M.(1);Fleischmann, D.(2);
(1)University Hospital Regensburg, Department of Internal Medicine I- Gastroenterology- Hepatology- Endocrinology- Rheumatology and Infectious diseases, Regensburg, Germany;(2)University Hospital Regensburg, Hospital Pharmacy, Regensburg, Germany;
P1029: Prevalance and risk factors of thromboembolism in Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Katı, O.(1);Bakkaloglu, O.K.(2)*;Hatemi, I.(3);Celik, A.F.(3);Seyahi, E.(4);Erzin, Y.(3);
(1)Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Internal Medicine, Istanbul, Turkey;(2)KOSUYOLU HIGH SPECIALIZATION EDUCATION AND RESEARCH HOSPITAL, Gastroenterology, istanbul, Turkey;(3)Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Gastroenterology, Istanbul, Turkey;(4)Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey;
P102: Neuron-specific gene-2 aggravates colitis and colon tumorigenesis by controlling microbial composition.ECCO'24Year: 2024
Authors: Han, Y.M.(1)*;Jo, K.(2);Lee, C.H.(2);Yu, H.(2);Kim, K.W.(3);Kang, H.W.(3);Kim, J.W.(3);Koh, S.J.(2);
(1)Seoul National University Hospital Healthcare System Gangnam Center, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;(3)Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Department of Internal Medicine, Seoul, Korea- Republic Of;
P1030: Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s programECCO'24Year: 2024
Authors: Pipicella, J.L.(1,2,3)*;Wilson, W.(4,5);Ghaly, S.(6);Antoniades, S.(6);Kate, L.(7,8);Grafton, R.(7);Ng, W.(9);Sechi, A.(9);Somes, K.(10);Arnold, K.(11);Connor, S.J.(1,2,3,9);Andrews, J.M.(3,7,8);
(1)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Warwick Farm, Australia;(2)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(3)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(4)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(5)SA Health, Chief Medical Information Officer, Adelaide, Australia;(6)St Vincent@E@s Hospital Sydney, Gastroenterology, Darlinghurst, Australia;(7)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;(8)University of Adelaide, Faculty of Health and Medical Sciences, Adelaide, Australia;(9)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;(10)Campbelltown Hospital, Gastroenterology, Campbelltown, Australia;(11)Christchurch Hospital, Gastroenterology, Christchurch Central City, New Zealand;
P1031: Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis treated with upadacytynib.ECCO'24Year: 2024
Authors: Kaniewska, M.(1)*;Krogulecki, M.(2);Lewandowski, K.(3);Filipiuk, A.(2);Gonciarz, M.(2);Rydzewska, G.(3);
(1)National Medical Institute of the Ministry of Interior and Administration, Clinical Department of Internal Medicine and Gastroenterology, Warsaw, Poland;(2)Military Institute of Medicine-National Research Institute- Warsaw- Poland, Clinical Department of Gastroenterology and Internal Medicine, Warsaw, Poland;(3)National Medical Institute of the Ministry of Interior and Administration- Warsaw- Poland, Clinical Department of Internal Medicine and Gastroenterology, Warsaw, Poland;
P1032: Ileoanal Pouch Salvage Rates with Endoluminal Vacuum Therapy for Early vs. Late Anastomotic LeaksECCO'24Year: 2024
Authors: Alipouriani, A.(1);Lavryk , O.(1);Lipman , J.(1);Hull, T.(1);Steele, S.(1);Liska , D.(1);Holubar, S.(1)*;
(1)Cleveland Clinic Foundation, Department of Colorectal surgery, Cleveland, United States;
P1033: Road to exit strategy in patients with inflammatory bowel disease: ready or not?ECCO'24Year: 2024
Authors: Todeschini, A.(1)*;Ciccocioppo, R.(2);Geccherle, A.(1);Bernuzzi, M.(2);Signoretto, P.(1);Colaci, N.(3);Barugola, G.(4);Variola, A.(1);
(1)IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar di Valpolicella, Italy;(2)A.O.U.I. Policlinico G.B. Rossi and University of Verona, Gastroenterology Unit, Verona, Italy;(3)IRCCS Sacro Cuore Don Calabria, Clinical Research, Negrar di Valpolicella, Italy;(4)IRCCS Sacro Cuore Don Calabria, General Surgery, Negrar di Valpolicella, Italy;
P1035: CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn’s disease resistant to infliximabECCO'24Year: 2024
Authors: Wang, Y.(1)*;Zhou, Z.(2);Luo, Z.(3);Li, X.(1);
(1)The First Affiliated Hospital of Sun Yat-Sen University, Department of Radiology, Guangzhou, China;(2)Sun Yat-Sen University, Zhongshan School of Medicine, Guangzhou, China;(3)Shenzhen University Medical School, Medical AI Lab- School of Biomedical Engineering, Shenzhen, China;
P1036: Persistence of biologics and advanced small molecules in 4th, 5th and 6th line of therapy for inflammatory bowel disease: a cross-sectional retrospective studyECCO'24Year: 2024
Authors: ParigiMD, T.L.(1)*;Massimino, L.(1);Carini, A.(1);Allocca, M.(1);D@E@Amico, F.(1);Furfaro, F.(1);Zilli, A.(1);Cagliani, S.(1);Errico, C.(1);Facoetti, A.(1);Nicolò, S.(1);Peyrin-Biroulet, L.(2);Danese, S.(1);
(1)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(2)University of Lorraine, Inserm- NGERE- F-54000, Nancy, Italy;
P1037: Treatment sequences and time on specific treatments in patients with inflammatory bowel disease under advanced treatment – a German claims data analysisECCO'24Year: 2024
Authors: Dignass, A.(1)*;Teich, N.(2);Kudernatsch, R.(3);Sünwoldt, J.(3);Grellmann, C.(4);Sende, F.(4);Kaiser, S.(3);
(1)Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt/Main, Germany;(2)Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten, n/a, Leipzig, Germany;(3)Takeda Pharma Vertrieb GmbH & Co. KG, n/a, Berlin, Germany;(4)WIG2 Wissenschaftliches Institut für Gesundheitsökonomie und Gesundheitssystemforschung, n/a, Leipzig, Germany;
P1038: Does combination immunomodulator therapy impact real-world biologic effectiveness in Inflammatory Bowel Diseases?A propensity score analysis in patients treated with anti-TNF and non-anti-TNF biologics in the UK IBD BioResourceECCO'24Year: 2024
Authors: Desoki, R.(1,2)*;Kapizioni, C.(1,3);Lam, D.(1,4);Balendran, K.(1,5);Al-Sulais, E.(1,6);Subramanian, S.(1);Pele, L.(7,8);Parkes, M.(1);Raine, T.(1);
(1)Cambridge University Hospital, Department of Gastroenterology, Cambridge, United Kingdom;(2)Alexandria University, Department of Genetics, Alexandria, Egypt;(3)Attikon University Hospital, Department of Gastroenterology, Athens, Greece;(4)Sir Charles Gairdner Hospital, Department of Gastroenterology, Perth, Australia;(5)University of Jaffna, Department of Clinical Medicine, Jaffna, Sri Lanka;(6)King Fahad Specialist Hospital, Department of Gastroenterology, Dammam, Saudi Arabia;(7)University of Cambridge, Department of Medicine, Cambridge, United Kingdom;(8)IBD BioResource, NIHR BioResource, Cambridge, United Kingdom;
P103: Natural compounds in Ulcerative Colitis and Irritable Bowel Syndrome: Insights from immune-metabolic profilesECCO'24Year: 2024
Authors: McShane, C.(1,2,3)*;O@E@Connell, F.(4);Pigott, M.(5);Obaidi, I.(5);Sheridan, H.(5);Kevans, D.(2,6,7);O@E@Sullivan, J.(8);
(1)St. James@E@s Hospital, Department of Gastroenterology, Dublin, Ireland;(2)Trinity College Dublin, Trinity Academic Gastroenterology Group, Dublin, Ireland;(3)St. James’s Hospital, Wellcome – HRB Clinical Research Facility-, Dublin, Ireland;(4)St. James’s Hospital and Trinity College Dublin, Department of Surgery- Trinity St. James’s Cancer Institute and Trinity Translational Medicine Institute, Dublin, Ireland;(5)Trinity College Dublin, NatPro Centre- School of Pharmacy and Pharmaceutical Sciences, Dublin, Ireland;(6)St. James’s Hospital, Department of Gastroenterology, Dublin, Ireland;(7)St. James’s Hospital, Wellcome – HRB Clinical Research Facility, Dublin, Ireland;(8)Department of Surgery- Trinity St. James’s Cancer Institute and Trinity Translational Medicine Institute, St. James’s Hospital and Trinity College Dublin, Dublin, Ireland;
P1040: Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn’s disease: a matching-adjusted indirect comparisonECCO'24Year: 2024
Authors: Ma, C.(1)*;Dubinsky, M.C.(2);Axelrad, J.(3);Anyanwu, S.(4);Tran, J.(5);Lacerda, A.(4);Joshi, N.(4);Griffith, J.(4);
(1)University of Calgary, Inflammatory Bowel Disease Clinic- Department of Medicine, Calgary, Canada;(2)Icahn School of Medicine- Mount Sinai, Division of Pediatric Gastroenterology and Nutrition, New York, United States;(3)NYU Grossman School of Medicine, Department of Medicine- Division of Gastroenterology, New York, United States;(4)AbbVie Inc., n/a, Chicago, United States;(5)AbbVie Inc. and Comparative Health Outcomes- Policy- and Economics Institute- University of Washington, n/a, Seattle, United States;
P1041: Coconut water modulates dietary potassium and gut microbiome to induce remission in ulcerative colitis: randomized controlled trialECCO'24Year: 2024
Authors: Kedia, S.(1);Virmani, S.(1);Bajaj, A.(1);Markandey, M.(1);Singh, N.(1);Madan, D.(1);Kaushal, K.(1);Sahu, P.(1);Vuyyuru, S.(1);Kante, B.(1);Kumar, P.(1);Thomas, D.(1);Mundhra, S.(1);Singh, M.(1);Verma, M.(1);Sharma, R.(2);Das, P.(3);Dash, N.(4);Monga, N.(5);Awasthi, A.(6);Makharia, G.(1);Ahuja, V.(1)*;
(1)All India Institute of Medical Sciences, Gastroenterology, New Delhi, India;(2)All India Institute of Medical Sciences, Radiodiagnosis, New Delhi, India;(3)All India Institute of Medical Sciences, Pathology, New Delhi, India;(4)All India Institute of Medical Sciences, G I Surgery, New Delhi, India;(5)Indian Council of Medical Research, Non-communicable Disease Division, New Delhi, India;(6)Translational Health Science and Technology Institute, Infection and Immunology, Faridabad, India;
P1042: Serum N-glycan Biomarkers Predict Patient Response to Biologics for Crohn’s DiseaseECCO'24Year: 2024
Authors: Elgood Hunt , G.(1)*;Spencer , D.(1);Senard , T.(1);Gardner , R.(1);Satsangi , J.(2);Adams , A.(2);Noble , A.(2);D’Haens , G.(3);Joustra , V.(3);Li Yim , A.(3);J. de Jonge , W.(3);
(1)Ludger, Research and Development, Oxford, United Kingdom;(2)Oxford University, Experimental Medicine Division, Oxford, United Kingdom;(3)University Medical Centre, Dept of Gastroenterology and Hepatology, Amsterdam UMC, The Netherlands;
P1043: Immunomodulator and advanced therapies for prevention of clinical relapse and loss of response during maintenance phase in Crohn’s disease: A systematic review and network meta-analysisECCO'24Year: 2024
Authors: Sinopoulou, V.(1);Gordon, M.(1);Vuyyuru, S.(2)*;Darie, A.M.(3);Pavlidis, P.(4);Moran, G.(5);
(1)University of Central Lancashire, School of Medicine and dentistry, Preston, United Kingdom;(2)Nottingham University Hospitals NHS trust, Gastroenterology, Nottingham, United Kingdom;(3)Nottingham University Hospitals- NHS trust, Gastroenterology, Nottingham, United Kingdom;(4)King’s College Hospital- London- UK- School of Immunology and Microbial Sciences- King@E@s College London- London- UK, Department of Gastroenterology, London, United Kingdom;(5)Nottingham University Hospitals NHS trust- Nottingham- UK- Nottingham NIHR Biomedical Research Centre- Nottingham- UK- Translational medical sciences- School of Medicine- Faculty of Medicine and Health science- University of Nottingham- UK, Gastroenterology, Nottingham, United Kingdom;
